Entdecke BaseLaunch
BaseLaunch ist Europas führende Plattform für den Aufbau der nächsten Generation von Biotech-Unternehmen – und hilft Wissenschaftlern und Unternehmern, Durchbrüche in investierbare Unternehmen zu überführen. Wir schliessen die Lücke zwischen Forschung und Series A und beseitigen Barrieren beim Zugang zur Industrie, beim Unternehmensaufbau und bei der Finanzierung.
Erhalte bis zu CHF 500’000, um wissenschaftliche Risiken zu reduzieren – ergänzt durch Expertise zu Indikationsstrategie, Unternehmensaufbau, IP und mehr.
Mit Partnern wie AbbVie, CSL, Johnson & Johnson, Novo Nordisk, Pureos Bioventures, Roche und Takeda schärfst du deine Positionierung, ziehst Investoren an und beschleunigst dein Wachstum. Unser Portfolio umfasst 29 Unternehmen, die gemeinsam über CHF 800 Millionen eingeworben haben – ein klarer Beweis dafür, dass die Formel funktioniert.
Häufig gestellte Fragen
BaseLaunch is Europe’s leading biotech venture builder, operated by Basel Area Business & Innovation. It helps scientists and entrepreneurs build world-class biotech companies by providing funding, hands-on company-building support, and access to a network of global pharma and venture partners.
The program is open to academic founders, researchers and biotech entrepreneurs developing breakthrough therapeutics or drug-discovery platforms.
Selected ventures can receive up to CHF 500,000 as a convertible loan to advance their science, plus extensive guidance on company creation, IP, indication strategy and business development. BaseLaunch’s industry partners — including AbbVie, CSL, Johnson & Johnson, Novo Nordisk, Pureos Bioventures and Roche — provide direct expertise.
Since its inception, BaseLaunch has supported over 29 biotech companies that have collectively raised more than CHF 800 million in financing. Many have entered strategic partnerships with leading global pharmaceutical firms, underscoring the program’s effectiveness in turning cutting-edge science into investable ventures.
BaseLaunch combines funding with deep scientific and strategic expertise. Rather than following a fixed cohort model, it tailors its support to each project’s needs and stage, focusing on quality over quantity and building sustainable companies that can attract major investors.
Applications are accepted through the BaseLaunch website based on the next application deadline. Founders submit a non-confidential deck and answer questions about their technology, data and goals. The applications are reviewed after the deadline and selected projects are invited to the next step.